SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-19-010438
Filing Date
2019-06-10
Accepted
2019-06-10 17:00:16
Documents
2
Group Members
MOBIGO INC.N.DANENBERG HOLDINGS (2000) LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D sc13d0619a1danenberg_wize.htm SC 13D/A 103395
2 JOINT FILING AGREEMENT AMONG NOAM DANENBERG, MOBIGO AND NDH sc13d0619a1ex99-1_wize.htm EX-99.1 9020
  Complete submission text file 0001213900-19-010438.txt   113896
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 19889113
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 BOROCHOV ST HOD HASHARON L3 4520404
Business Address
Danenberg Noam (Filed by) CIK: 0001720898 (see all company filings)

Type: SC 13D/A